We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Kimberly McBennett, MD, PhD

Kimberly McBennett, MD, PhD

  • Specialty: Internal Medicine, Pediatric Pulmonology
    View Expertise
  • Primary Location: 3800 Embassy Pkwy (25 mi.)
    Other Locations
  • Languages Spoken: English

Office Locations

UH Fairlawn Health Center (25 mi.)

3800 Embassy Pkwy
Ste 250
Akron, OH 44333

RBC Rainbow Babies & Childrens (0 mi.)

11100 Euclid Ave
Ste 170
Cleveland, OH 44106

RBC Rainbow Babies & Childrens (0 mi.)

11100 Euclid Ave
Ste 604
Cleveland, OH 44106

RBC 34055 Solon (12 mi.)

34055 Solon Rd
Ste 200
Solon, OH 44139

Biography: Kimberly McBennett, MD, PhD


  • Cystic Fibrosis
  • Internal Medicine


  • Assistant Professor of Medicine, CWRU School of Medicine
  • Associate Professor of Pediatrics, CWRU School of Medicine

Certifications & Memberships

  • Hospice and Palliative Medicine - American Board of Internal Medicine
  • Internal Medicine - American Board of Internal Medicine


Residency | Internal Medicine
Internal Medicine - Akron City Hospital (Summa Health System) (2004 - 2005)

Residency | Internal Medicine/Pediatrics
Internal Medicine/Pediatrics - Akron Children's Hospital (2001 - 2004)

Medical Education
Northeast Ohio Medical University (NEOMED) (2001)

Other Education
Kent State University (1999)

University Of Pittsburgh At Johnstown (1993)


Kimberly McBennett, MD, PhD is a specialist and clinical educator in pediatric pulmonary (lung) disease in the Division of Pediatric Pulmonology, Allergy, Immunology and Sleep Medicine at University Hospitals Rainbow Babies & Children’s Hospital since 2014. She sees patients at UH Rainbow Babies & Children’s main campus in Cleveland, OH.

Dr. McBennett trains fellows in the adult Cystic Fibrosis rotation and is a lecturer in the fellowship's core lecture series.

Dr. McBennett is board certified in hospice and palliative medicine and internal medicine. Her academic interests include adult Cystic Fibrosis, palliative care, and nutrition. Her research focuses on the use of MRI to detect early systemic disease in Cystic Fibrosis patients, Cystic Fibrosis quality improvement and is involved in Cystic Fibrosis clinical trials.

Featured Videos

Watch to find out more about this University Hospitals provider.

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Kimberly McBennett did not disclose any Outside Relationships with Industry.